BLN RSS





Enter your email address:

News, Blogs,
Information, and Analysis

What Really Happened
Information Liberation
Cryptogon
Strat Risks
Raw Story
Citizens for Legit Gov.
Full Specturm Dominance
Information Clearing House
Boiling Frog Post
Global Research
The Peoples Voice
Tom Burghardt
Michael Snyder
Tony Cartalucci
Madison Ruppert
Steve Quayle
Wayne Madsen
Uncover The News
All Gov.
Media Monarchy
Andrew Gavin Marshall
F. William Engdahl
Cryptome
Corbett Report
Common Dreams
Alternet
Antiwar
VICE
Aftermath News
Truth Out
Lew Rockwell
Dissident Voice
Sovereign Independent
Before It's News
News With Views
Jeff Rense
Strike The Root
Old Thinker News
Deadline
Activist Post
No Agenda News
Empire Burlesque
CNS News
Dark Politricks
Stop The Lie
Amy de Miceli
Rumor Mill News
The Resident
Aangirfan
OpEDNews
The Brad Blog
Conspiracy Archive
Foreign Policy Journal
Counter Punch
A Little Rebellion
Truth Dig
Truth Is Treason
Reason
Real News Network
VOA News
Huffington Post
Grist
World Net Daily
Drudge Report
Salon
Reality Sandwich
MikesNewsNet
Red Ice
Newsmax
Boing Boing
Short News
Counter PsyOps
Small Government Times
The Blotch
Wide Awake News
News Blok 2
Against The Wall
Disinformation
Vigilant Citizen
Amped Status
Federal Jack
SHTF Plan
ITHP
The Daily Bell
The Excavator
Phantom Report
NewsWires
Breaking News
Yahoo News
Google News
Community News Aggregators
Reddit
Digg
Business / Economics
Silver and Gold Prices
Max Keiser
Naked Capitalism
Business Insider
Market Watch
Bloomberg
Wall Street Journal
RTT News
CNN Money
Forbes
Business Week
Market Oracle
Money Morning
My Budget 360
Alt-Market
The Street
Shadow Stats
Economist
Financial Times
Fortune Magazine
Daily Crux
Stock Charts
Zero Hedge
Washingtons's Blog
The Daily Reckoning
Energy Business Review
Milplex / Intel / Defense
Oil Price
Global Post
Public Intelligence
Danger Room
Washington Technology
Defense Industry Daily
Global Security
Geopolitical Monitor
Defense Link
Space War
Jane's
Defense Tech
Strategy Page
Military Info Tech
Silo Breaker
Strategy Page
Homeland Sec. Newswire
Health & Environment
Natural News
Prevent Disease
Food Freedom
Farm Wars
Medial Express
Natural Society
Major US Newspapers
New York Times
New York Post
New York Daily News
Washington Post
Washington Times
L.A. Times
USA Today
Science / Tech News
Tech Dirt
Ars Technica
Wired
Blast Magazine
PHYSorg
Science Daily
Popular Science
Tech Eye
Engadget
New Scientist
DVice
Mother Board
Technovelgy
Singularity Hub
H+ Magazine
Science Magazine
Seed Magazine
CBR Online
Science News
SlashDot
Scientific American
Spectrum IEEE
Technology Review
io9
ZD Net
Technology News
The Register
Tech News World




Security System

Donate Today









FDA’s New Claim: “Your Body Is a Drug and We Have the Authority to Regulate It!”

February 1, 2012

Source: Alliance for Natural Health

In another outrageous power-grab, FDA says your own stem cells are drugs—and stem cell therapy is interstate commerce because it affects the bottom line of FDA-approved drugs in other states!

We wish this were a joke, but it’s the US Food and Drug Administration’s latest claim in its battle with a Colorado clinic over its Regenexx-SD™ procedure, a non-surgical treatment for people suffering from moderate to severe joint or bone pain using adult stem cells.

The FDA asserts in a court document that it has the right to regulate the Centeno-Schultz Clinic for two reasons:

  1. Stem cells are drugs and therefore fall within their jurisdiction. (The clinic argues that stem cell therapy is the practice of medicine and is therefore not within the FDA’s jurisdiction!)
  2. The clinic is engaging in interstate commerce and is therefore subject to FDA regulation because any part of the machine or procedure that originates outside Colorado becomes interstate commerce once it enters the state. Moreover, interstate commerce is substantially affected because individuals traveling to Colorado to have the Regenexx procedure would “depress the market for out-of-state drugs that are approved by FDA.”

We discussed the very ambiguous issue of interstate commerce last September—it’s an argument the FDA frequently uses when the basis for their claim is otherwise lacking. As we noted then, the FDA holds that an “interstate commerce” test must be applied to all steps in a product’s manufacture, packaging, and distribution. This means that if any ingredient or tool used in the procedure in question was purchased out of state, the FDA would in its view have jurisdiction, just as they would if the final product had traveled across state lines.

This time the FDA just nakedly says in court documents that the agency wants to protect the market for FDA-approved drugs. No more beating around the bush—their agenda is right out in the open! This appears to be a novel interpretation of the Food Drug and Cosmetic Act (FD&C), as evidenced by the government’s failure to cite any judicial precedent for their argument.

The implication of the FDA’s interpretation of the law, if upheld by the court, would mean that all food, drugs, devices, and biologic or cosmetic products would be subject to FDA jurisdiction. The FDA is expanding its reach even to commerce within the state, which we argue is far beyond its jurisdiction, in order to protect drug company profits.

Last year we ran a two-part series on the current status of federal and state law—and FDA jurisdiction—and how it affects integrative treatments (part one and part two).

The Centeno-Schultz Clinic takes your blood, puts it into a centrifuge machine that separates the stem cells, and a doctor puts them back in your body where there is damaged tissue. The clinic has argued numerous times that stem cells aren’t drugs because they are components of the patient’s blood from his or her own body.

The FDA says otherwise: “Stem cells, like other medical products that are intended to treat, cure, or prevent disease, generally require FDA approval before they can be marketed. At this time, there are no licensed stem cell treatments.” There they go again, saying that components of your body are drugs and they have the authority to regulate them! It’s the only way the agency can claim that adult stem cell therapy is within FDA’s purview.

However, the agency seems to be of two minds. When ESPN magazine was doing a story on stem cell treatments, the FDA stated that US policy is to allow the injection of stem cells that are treated with “minimal manipulation,” which federal regulations define as “processing that does not alter the relevant biological characteristics of cells or tissues”—which is certainly the case with the Regenexx clinic.

Despite this policy, FDA has been attacking the clinic for the past four years. They have tried injunctions and demanded inspections in their attempts to make the company bend; this court battle is merely the latest salvo.

The primary role of adult stem cells in a living organism is to maintain and repair the tissue in which they are found. The hard part has been to get enough of them. But new technology is giving doctors the ability to obtain more stem cells from a patient than previously thought possible, which is why we’re now seeing new treatments. Blood, fat, or tissue is withdrawn from the patient, stem cells are obtained using one of these new processes, and the cells are injected back into the patient where they can repair the patient’s tissue.

Gov. Rick Perry received this kind of stem cell therapy. We and others noted that the governor’s defense of freedom of healthcare choice when it came to his own treatment was starkly at odds with his directive to administer HPV vaccines to young girls against their own (and their parents’) wishes. It’s also at odds with his support for some of the most egregious witch-hunters on the Texas State Medical Board, which he appoints.

Behind Perry’s blatant inconsistency and the latest FDA attempted power grab lies the same problem: a medical system run by special interests under the leadership of the US government, the same government that is supposed to represent “we the people.”

Read the Full Article Here: http://www.anh-usa.org/fda-new-claim-body-is-a-drug/